H2-Db Antibodies

Santa Cruz Biotechnology offers a broad range of H2-Db monoclonal antibodies for advanced research in immunology and cellular biology. H2-Db monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). H2-Db is a major histocompatibility complex (MHC) class I molecule that plays a critical role in the immune response by presenting endogenous antigens to CD8+ T cells. MHC class I molecules are essential for the recognition of infected or malignant cells, making them key players in the development of immune therapies and vaccine strategies. Understanding the function and regulation of MHC class I molecules advances knowledge of immune system dynamics and improves therapeutic interventions. Researchers worldwide rely on H2-Db monoclonal antibodies to investigate immune responses in various experimental conditions. The specificity and reliability of H2-Db monoclonal antibodies enable precise detection and characterization of MHC class I molecules in diverse research applications. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of immune system mechanisms and developing new therapeutic strategies.